While this result was not significant after correction for multiple comparisons (P > .0005), this variant is rare in the general population (MAF: 0.002), whereas it occurred in 6 patients with MS (14.0%), 1 patient with another AID (6.3%), and 1 healthy individual (1.8%). This evidence concerns the gene AICDA and myeloid sarcoma.